melphalan and Sleep-Initiation-and-Maintenance-Disorders

melphalan has been researched along with Sleep-Initiation-and-Maintenance-Disorders* in 2 studies

Other Studies

2 other study(ies) available for melphalan and Sleep-Initiation-and-Maintenance-Disorders

ArticleYear
A good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2017, Volume: 24, Issue:sup1

    Topics: Antineoplastic Agents, Alkylating; Dyspnea; Fatigue; Humans; Immunoglobulin Light-chain Amyloidosis; Melphalan; Pain; Prospective Studies; Quality of Life; Sleep Initiation and Maintenance Disorders; Treatment Outcome

2017
Bortezomib-induced Sweet's syndrome.
    Haematologica, 2005, Volume: 90, Issue:12 Suppl

    Sweet's syndrome is an uncommon acute skin disease, associated with a variety of medical problems. The drug-induced variant is even rarer. We describe two cases of this syndrome associated with the administration of the proteasome inhibitor bortezomib. The diagnostic criteria for drug-induced Sweet's syndrome as proposed by Walker and Cohen were fulfilled. Vasculitis and neutrophilic eccrine hidradenitis were excluded.

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Drug Administration Schedule; Erectile Dysfunction; Humans; Immunosuppressive Agents; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Pain; Peripheral Nervous System Diseases; Prednisolone; Protease Inhibitors; Pyrazines; Recurrence; Sleep Initiation and Maintenance Disorders; Sweet Syndrome; Testicular Diseases

2005